An Observational Study Assessing Changes in Health and Functional Status in Patients with Chronic Obstructive Pulmonary Disease (COPD) During Therapy with Spiolto^® Respimat^® in Everyday Clinical Practice: The Greek ELLACTO Study.

ABSTRACT:

Introduction

Patients with chronic obstructive pulmonary disease (COPD) often report deteriorated functional status and poor health-related quality of life, both core aspects of their overall health status. The study objective was to assess tiotropium/olodaterol Respimat^® effects on health and functional status of COPD patients requiring long-acting dual bronchodilation treatment in the real world.

Methods

ELLACTO was an open-label, observational, prospective study conducted in Greece, measuring changes on health and functional status of COPD patients treated with a fixed dose of tiotropium/olodaterol Respimat^® for approximately 6 weeks. The primary endpoint was "therapeutic success" defined as a ≥ 0.4-point decrease in the Clinical COPD Questionnaire (

SUBMITTER: Kosmas E 

PROVIDER: S-EPMC8589918 | biostudies-literature | 2021 Dec

REPOSITORIES: biostudies-literature